Cargando...

Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.

Seven patients with gut and pancreatic endocrine tumours have been treated with a long acting somatostatin analogue (SMS 201-995), given as a twice daily subcutaneous injection. This produced dramatic improvement in their endocrine related symptoms, in association with a fall in circulating tumour p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wood, S M, Kraenzlin, M E, Adrian, T E, Bloom, S R
Formato: Artigo
Lenguaje:Inglês
Publicado: 1985
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1432669/
https://ncbi.nlm.nih.gov/pubmed/2860052
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!